Walder Wyss advised SixPeaks Bio AG while Lenz & Staehelin acted as Swiss counsel to AstraZeneca. SixPeaks Bio AG has secured USD30 million in Series A...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised the selling shareholders of RIRI Group in this transaction. Homburger advised OC Oerlikon. Oerlikon, a global innovation provider for surface engineering, polymer...
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey acted as Swiss legal advisor to the banking syndicate in this transaction comprising the Global Coordinator, 4 other Joint Lead Managers and 15...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Credit Suisse in this transaction. Credit Suisse Asset Management sold its minority stake in Energy Infrastructure Partners AG to the company’s co-founders...
You must be a Standard 1 Year member to access this content.
Cravath and Lenz & Staehelin represented Taro in connection with the transaction. Ropes & Gray advised Galderma. Taro Pharmaceutical Industries Ltd. (“Taro”), a multinational, science-based pharmaceutical...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised SKAN Group AG on the deal. SKAN Group AG announced the pricing of its IPO, consisting of 1,731,494 newly issued shares and...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Credit Suisse on the structuring and disposing of the economic interest in its real estate leasing portfolio, while Baker McKenzie has advised...
You must be a Standard 1 Year member to access this content.
Bär & Karrer has acted as lead counsel to Lonza in this transaction. Lenz & Staehelin, Freshfields Bruckhaus Deringer, Kirkland & Ellis and Elvinger Hoss Prussen...
You must be a Standard 1 Year member to access this content.
